297 filings
Page 2 of 15
8-K
go9rw6
9 Nov 20
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
7:20am
DEFA14A
yc2 z929uxpmg5
5 Nov 20
Additional proxy soliciting materials
7:01am
DEFA14A
uxbmg7 8fwptbio6
2 Nov 20
Additional proxy soliciting materials
8:08am
8-K
ci9v27 558fki
2 Nov 20
Liquidia Reschedules Special Meeting of Stockholders and Reaffirms Recommendation to Approve Proposed Acquisition of RareGen, LLC
8:04am
DEFA14A
lg8d cmkm
19 Oct 20
Additional proxy soliciting materials
8:37am
8-K
g0hmvyzih
19 Oct 20
Liquidia Announces Postponement of Special Meeting of Stockholders
8:35am
8-K
bb1kr95sgl
14 Oct 20
Liquidia Provides Update on U.S. Patent Trial and Appeal Board Decision on Inter Partes Review of Two United Therapeutics’ Tyvaso® Patents
4:16pm
DEFA14A
mjsy4gzw3en 2ge
8 Oct 20
Additional proxy soliciting materials
4:01pm
DEFA14A
ekls0g8d4kwgh5rk5y7j
18 Sep 20
Additional proxy soliciting materials
4:32pm
425
5uj7ae1
18 Sep 20
Business combination disclosure
4:30pm
DEFA14A
6tmo6ljd
17 Sep 20
Additional proxy soliciting materials
7:22am
425
1l5sp2rgcp0
17 Sep 20
Business combination disclosure
7:20am
DEFM14A
ug0n0u1ke
17 Sep 20
Proxy related to merger
12:00am
3
fzevhgy4o
21 Aug 20
Liquidia / Steven Bariahtaris ownership change
7:07pm
DEFA14A
qyo4y6b
20 Aug 20
Additional proxy soliciting materials
9:22am
425
inpw3mdu m5md
20 Aug 20
Business combination disclosure
9:21am
8-K
og9a8x
20 Aug 20
Liquidia Announces Chief Financial Officer Transition
9:20am
DEFA14A
eb6o5il8cvfe5
10 Aug 20
Additional proxy soliciting materials
7:22am